Navigation Links
GeneCopoeia Introduces Genome-Wide MicroRNA (miRNA) Functional Analysis Tools

GERMANTOWN, Md., March 5 /PRNewswire/ -- GeneCopoeia announces the launch of a suite of miRNA functional analysis reagents and tools. They include 1) miExpress(TM) vector based precursor miRNA expression clones; 2) miTarget(TM) miRNA target sequence (3' UTR) expression clones; and 3) All-in-One(TM) miRNA RT-qPCR system.

Constructed in a lentiviral vector system, miExpress(TM) precursor miRNA expression clone collections cover all known miRNAs for human (750), mouse (450), and rat (270). These lentiviral vector based expression constructs allow efficient transduction of miRNAs into dividing and non-dividing cells transiently or stably, and can be used for in vitro assays and in vivo animal studies. The transduction efficiencies are monitored by the expression level of an indicator/reporter gene.

miTarget(TM) miRNA target sequence (3' UTR) expression clones cover genome-wide human, mouse and rat genes. These expression ready constructs are made in a mammalian expression vector system with dual reporter genes, which provides a ready-for-use and single vector solution for both transcriptional regulation reporting and an internal control for normalization reporting.

In addition to the two types of expression constructs, GeneCopoeia plans to launch All-in-One(TM) miRNA RT-qPCR system in the next few weeks. This system consists of a reverse transcription kit, a SYBR green RT-qPCR master mix kit, and a complete set of validated primers for human, mouse, and rat miRNAs, which allows specific and sensitive quantification of miRNAs individually or in an array format.

GeneCopoeia also plans to release soon a set of vector based miRNA suppressor construct products currently in development. Together with other miRNA products aforementioned, this product line will provide a complete set of tools and solutions for miRNA functional analysis.

For more information, please visit:

About GeneCopoeia

GeneCopoeia, Inc is a Maryland, US, based manufacturer and provider of a wide range of biological and biomedical research reagent products as well as a full spectrum of custom services. GeneCopoeia, together with its joint venture, FulenGen, has produced the largest number of full-sequence-verified human and mouse full length protein coding ORF cDNA clones, which are offered to customers in more than 80 vectors with a choice of over 50 different fusion tags.

    Sun Lu, Ph. D.
    19520 Amaranth Drive
    Germantown, Maryland 20874
    Tel: 301-515-6982
    Fax: 301-515-6983

SOURCE GeneCopoeia, Inc
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Video: Schering-Plough Introduces AFRIN(R) PureSea(TM): A Natural, Gentle Nasal Rinse From the Seas of Northern France
2. Sigma-Aldrich Introduces MISSION(R) LentiPlex(TM) Pooled shRNA Libraries to Enable Rapid Whole Genome Screening in Primary Cells, Stem Cells or Tumor Cells
3. MaxCyte Introduces the GT(TM) Flow Transfection System for Application with Autologous and Allogeneic Stem Cell Therapies
4. Max Muscle Introduces First-Ever Probiotics Protein Bar
5. bioMerieux Introduces Surveillance Tool to Fight Healthcare-Associated Infections
6. Caliper Life Sciences Introduces Zephyr Genomics Workstation for Automated Liquid Handling
7. Pioneering Cancer Center Introduces Advanced Varian RapidArc(TM) Treatments for Cancer Patients in Central Germany
8. Elsevier Introduces Breakthrough Technology Intelligence Solution for Accelerating R&D and Innovation in Europe
9. Cell Biosciences Introduces Kits for Oncoprotein Analysis
10. International Robotic Urology Symposium Reports on Benefits of Cooling During Robotic-Assisted Prostate Surgery and Introduces InnerCools New Investigational UroCool System
11. GEMS Introduces Ultrasonic Continuous Liquid Level Sensor for Challenging Fluid Measurement
Post Your Comments:
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Ky. , June 23, 2016 ... two Phase 1 clinical trials of its complement ... placebo-controlled, single and multiple ascending dose studies designed ... pharmacodynamics (PD) of subcutaneous injection in healthy adult ... subcutaneously (SC) either as a single dose (ranging ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance Associates® Inc. (RCA), ... free webinar on Performing Quality Investigations: Getting to Root Cause. ... no charge. , Incomplete investigations are still a major concern to the Regulatory ...
Breaking Biology Technology:
(Date:5/12/2016)... 12, 2016 , a brand ... overview results from the Q1 wave of its quarterly ... was consumers, receptivity to a program where they would ... health insurance company. "We were surprised to ... Michael LaColla , CEO of Troubadour Research, "primarily ...
(Date:4/28/2016)... India , April 28, 2016 ... Infosys (NYSE: INFY ), and Samsung SDS, a ... that will provide end customers with a more secure, ... services.      (Logo: ) , ... services, but it also plays a fundamental part in enabling ...
(Date:4/26/2016)... Research and Markets has announced ... 2016-2020"  report to their offering.  , ,     (Logo: ... analysts forecast the global multimodal biometrics market to ... period 2016-2020.  Multimodal biometrics is being ... the healthcare, BFSI, transportation, automotive, and government for ...
Breaking Biology News(10 mins):